An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body's own capacity to fight malignancies by activating an inflammation process that counter's the ability of cancer cells ...
Sep 20, 2017
0
153
The Warburg Effect describes a phenomenon in which cancer cells voraciously consume glucose for energy—something scientists have long known, yet have had little success exploiting as a way to stunt tumor growth.
Sep 14, 2017
0
2796
Surviving cardiac arrest often seems like a matter of luck—whether a passerby knows CPR, or a defibrillator is close at hand or the ambulance arrives quickly.
Aug 30, 2017
0
0
The push to develop treatments for Alzheimer's disease has been a promising and disappointing endeavor over the past two decades, yielding a greater understanding of the disease yet still failing to generate successful new ...
Jul 28, 2017
0
50
Mutations in the BRCA gene correspond to a higher lifetime risk of developing breast and ovarian cancers, and many women who carry these mutations consider undergoing mastectomy or removal of the ovaries and fallopian tubes ...
Jul 11, 2017
0
20
A team of hearing experts at Duke University School of Medicine and the Duke Global Health Institute is calling for a comprehensive, worldwide initiative to combat hearing loss.
Jul 10, 2017
0
1
Long before the Zika virus became a global fear, cytomegalovirus, or CMV, was commonly infecting developing fetuses and causing many of the same brain and developmental impairments.
Jul 6, 2017
0
27
Adding an investigational antibody to the chemotherapy rituximab appears to restore its cancer-killing properties in certain leukemia patients with a natural resistance to the drug, according to a small, proof-of-concept ...
Jun 28, 2017
0
4
Recent research on Parkinson's disease has focused on the gut-brain connection, examining patients' gut bacteria, and even how severing the vagus nerve connecting the stomach and brain might protect some people from the debilitating ...
Jun 15, 2017
0
1956
Building on insights from an HIV vaccine regimen in humans that had partial success during a phase 3 clinical trial in Thailand, a Duke-led research team used a more-is-better approach in monkeys that appeared to improve ...
Jun 8, 2017
1
55
